Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation

Journal of Allergy and Clinical Immunology

Volumn 138, Issue 2, 2016, Pages 628-630.e2

  Hsu, Amy P ^a   West, Robert R ^b   Calvo, Katherine R ^c   Cuellar Rodriguez, Jennifer ^d   Parta, Mark ^e   Kelly, Susan J ^f   Ganson, Nancy J ^f   Hershfield, Michael S ^f   Holland, Steven M ^a   Hickstein, Dennis D ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; AMPHOTERICIN B LIPID COMPLEX; CORTICOSTEROID; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; POSACONAZOLE; TRANSCRIPTION FACTOR GATA 2; CECR1 PROTEIN, HUMAN; GATA2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; COMMON VARIABLE IMMUNODEFICIENCY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; FUSARIOSIS; FUSARIUM PROLIFERATUM; GENE MUTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LYMPHOCYTOPENIA; MAXILLA SINUSITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MONOCYTOPENIA; NEUTROPENIA; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; SEQUENCE ANALYSIS; SYSTEMIC MYCOSIS; YOUNG ADULT; ADOLESCENT; AGAMMAGLOBULINEMIA; CHILD; DEFICIENCY; DIAGNOSTIC ERROR; GENETICS; HAPLOIDENTICAL TRANSPLANTATION; MALE; PRESCHOOL CHILD; SEVERE COMBINED IMMUNODEFICIENCY; STOP CODON; WHOLE EXOME SEQUENCING;

ADENOSINE DEAMINASE; ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; CHILD; CHILD, PRESCHOOL; CODON, NONSENSE; DIAGNOSTIC ERRORS; FEMALE; GATA2 TRANSCRIPTION FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; SEVERE COMBINED IMMUNODEFICIENCY; TRANSPLANTATION, HAPLOIDENTICAL; WHOLE EXOME SEQUENCING; YOUNG ADULT;

EID: 84964687196     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.03.016     Document Type: Article

References (11)

1. 1 Hsu, A.P., Sampaio, E.P., Khan, J., Calvo, K.R., Lemieux, J.E., Patel, S.Y., et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118 (2011), 2653–2655.
2. 2 Navon Elkan, P., Pierce, S.B., Segel, R., Walsh, T., Barash, J., Padeh, S., et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370 (2014), 921–931.
3. 3 Zhou, Q., Yang, D., Ombrello, A.K., Zavialov, A.V., Toro, C., Zavialov, A.V., et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370 (2014), 911–920.
4. 4 Ganapathi, K.A., Townsley, D.M., Hsu, A.P., Arthur, D.C., Zerbe, C.S., Cuellar-Rodriguez, J., et al. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood 125 (2015), 56–70.
5. 5 Pasquet, M., Bellanne-Chantelot, C., Tavitian, S., Prade, N., Beaupain, B., Larochelle, O., et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood 121 (2013), 822–829.
6. 6 Poursharifi, P., Saghiri, R., Ebrahimi-Rad, M., Nazem, H., Pourpak, Z., Moin, M., et al. Adenosine deaminase in patients with primary immunodeficiency syndromes: the analysis of serum ADA1 and ADA2 activities. Clin Biochem 42 (2009), 1438–1443.
7. 7 Gonzalez Santiago, T.M., Zavialov, A., Saarela, J., Seppanen, M., Reed, A.M., Abraham, R.S., et al. Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa. JAMA Dermatol 151 (2015), 1230–1234.
8. 8 Van Eyck, L. Jr., Hershfield, M.S., Pombal, D., Kelly, S.J., Ganson, N.J., Moens, L., et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol 135 (2015), 283–287.e5.
9. 9 van Montfrans, J., Zavialov, A., Zhou, Q., Mutant ADA2 in vasculopathies. N Engl J Med, 371, 2014, 478.
10. Zhou, Q., Yang, D., Ombrello, A.K., Zavialov, A.V., Toro, C., Zavialov, A.V., et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370 (2014), 911–920.
11. Van Eyck, L. Jr, Hershfield, M.S., Pombal, D., Kelly, S.J., Ganson, N.J., Moens, L., et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol 135 (2015), 283–287.e5.